Pharmacists in Comanche, OK Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Ms. Sharla Kay Carr, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 513 Hillary, Suite B, Comanche, OK 73529 Phone: 580-439-8869 Fax: 580-439-2357 |
 Mr. William W Baker, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Oak Main, Comanche, OK 73529 Phone: 580-439-8846 Fax: 580-439-8847 |
Ms. Melody Ann Morgan, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1013 S 10th St, Comanche, OK 73529 Phone: 580-641-1276 |
Brett Colby Doyle, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 W Main Ave, Comanche, OK 73529 Phone: 580-439-8846 Fax: 580-439-8846 |
Dr. Ryan Allen Woody, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 513 Hillery Rd, Suite B, Comanche, OK 73529 Phone: 580-439-8869 Fax: 580-439-2357 |
Dr. Toby Neal Thompson, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 513 Hillery Rd, Comanche, OK 73529 Phone: 580-439-8869 Fax: 580-439-2357 |
Mr. Tommy Lynn Thompson, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 513 Hillary, Suite B, Comanche, OK 73529 Phone: 580-439-8869 Fax: 580-439-2357 |
News Archive
Scientists develop new technique to 'turn off' multi-drug resistance capabilities in cancer cells
The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.
E-cigarettes may function as "gateway drug" to marijuana and cocaine
Like conventional cigarettes, electronic cigarettes (or e-cigarettes) may function as a "gateway drug"—a drug that lowers the threshold for addiction to other substances, such as marijuana and cocaine—according to the 120th Shattuck lecture, presented to the Massachusetts Medical Society by Columbia researchers Denise and Eric Kandel and published today in the online edition of the New England Journal of Medicine.
Organizations across U.S. participating in Go Gold for Childhood Cancer Awareness campaign
Organizations in Atlanta – and across the country – are participating in the Go Gold for Childhood Cancer Awareness campaign this September. Coordinating this effort is the Aflac Cancer Center of Children's Healthcare of Atlanta along with the Stop Childhood Cancer Alliance that was created to be the driving force in increasing awareness of childhood cancer and enhancing support for the young people fighting this disease, as well as the clinicians and researchers helping them.
Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis
Raptor Pharmaceutical Corp., today announced it has completed enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 8 days ago